Released December 28, 2021 | SUGAR LAND
en
Researched by Industrial Info Resources (Sugar Land, Texas)--The North American Pharmaceutical & Biotech Industry reported tremendous growth in capital construction during the 2021 calendar year. The COVID-19 pandemic brought the life science industry to the fore, driven by supply chain issues, the "reshoring" of production, the need for new therapeutics and research and development (R&D) spending, among other factors.
The North American life science industry has seen almost 600 major capital project construction starts in 2021, with a total investment value (TIV) of more than $30 billion. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list of projects.
Click on the image at right for a graph detailing the top 10 plant parent companies for major capital project construction starts in 2021 in the North American Pharmaceutical & Biotech Industry.
The major U.S. life science hubs are on the West Coast (including California, the leading U.S. state, with 86 projects with a TIV of $6.5 billion), followed by the Mid-Atlantic region (led by North Carolina with 35 projects at $3.5 billion TIV), the New England region (led by Massachusetts with 59 projects, worth $4.7 billion TIV), and the Northeast region (led by Pennsylvania with 30 projects with a $1.9 billion TIV).
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn.
The North American life science industry has seen almost 600 major capital project construction starts in 2021, with a total investment value (TIV) of more than $30 billion. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list of projects.
Click on the image at right for a graph detailing the top 10 plant parent companies for major capital project construction starts in 2021 in the North American Pharmaceutical & Biotech Industry.The major U.S. life science hubs are on the West Coast (including California, the leading U.S. state, with 86 projects with a TIV of $6.5 billion), followed by the Mid-Atlantic region (led by North Carolina with 35 projects at $3.5 billion TIV), the New England region (led by Massachusetts with 59 projects, worth $4.7 billion TIV), and the Northeast region (led by Pennsylvania with 30 projects with a $1.9 billion TIV).
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn.
